Rituximab inhibits Kv1.3 channels in human B lymphoma cells via activation of FcγRIIB receptors

Authors:

Abstract
No abstract available
Funding Information
  • Department of Health and Human Services
  • National Institutes of Health (5R01-DK067110, 5R37-DK037963)

This publication has 49 references indexed in Scilit: